Cybin Shareholders Weigh Helus Pharma Rebrand, Eight-Member Board
MarketBeat
Cybin (NASDAQ:HELP), doing business as Helus Pharma, held its Annual General and Special Meeting of Shareholders, where shareholders were asked to consider resolutions related to the company’s auditor, board size, corporate name and director elections.
Eric So, the company’s co-founder and executiv
NASDAQ:HELP